Fig. 3From: Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteersDose-normalized (a) Cmax and (b) AUC0–∞ of surotomycin following administration of single oral doses of surotomycin. AUC0–∞, area under the concentration-time curve from 0 to infinity Cmax, maximum plasma concentrationBack to article page